ASP Isotopes to spin off Renergen holding via ENDRA merger, secures $50M financing

Filed June 25, 2026 · Period ending June 25, 2026 · ~1 min read

Key Changes

• high

  ASPI's wholly-owned subsidiary Noble Africa (holding Renergen Limited) will merge with an ENDRA Life Sciences subsidiary, with Noble Africa surviving and listing on Nasdaq as NOBA; ASPI to retain ~89% ownership post-close.

  Item 7.01 — Regulation FD Disclosure verify on EDGAR →
• high

  Noble Africa secured $50M private placement commitments, with ASPI investing $20M as lead investor and other investors (including $750K from ASPI directors/management) contributing $30M; financing closes immediately before merger.

  Item 7.01 — Regulation FD Disclosure verify on EDGAR →
• medium

  Both boards approved the transaction, expected to close Q3-Q4 2026 subject to SEC registration effectiveness, ENDRA stockholder approval, and customary conditions.

  Item 7.01 — Regulation FD Disclosure verify on EDGAR →